BIO-TECHNE Corp Increase (Decrease) in Income Taxes Payable
BIO-TECHNE Corp (TECH) reported Increase (Decrease) in Income Taxes Payable of -$23.05 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2026-08-24
- BIO-TECHNE Corp increase (decrease) in income taxes payable for the quarter ending 2026-06-30 was -$10.01M, a 161.13% decline year-over-year.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for the quarter ending 2026-03-31 was $9.79M, a 324.77% increase year-over-year.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for the quarter ending 2025-12-31 was $4.58M.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for the quarter ending 2025-09-30 was -$27.40M.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for fiscal 2026 was -$23.05M, a 372.18% decline from fiscal 2025.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for fiscal 2025 was $8.47M.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for fiscal 2024 was -$10.60M.
- BIO-TECHNE Corp increase (decrease) in income taxes payable for fiscal 2023 was -$2.49M, a 193.44% decline from fiscal 2022.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 6 month as first filed | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 9 month as first filed | Increase (Decrease) in Income Taxes Payable 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$223.00K derived: sum of 2 quarters · filed 2026-08-24 | $4.35M derived: sum of 3 quarters · filed 2026-08-24 | -$23.05M 10-K · filed 2026-08-24 | |||
| 2026-03-31 | $9.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $14.37M derived: sum of 2 quarters · filed 2026-05-06 | -$13.04M 10-Q · filed 2026-05-06 | $3.34M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-12-31 | $4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | -$22.83M 10-Q · filed 2026-02-04 | -$6.45M derived: sum of 3 quarters · filed 2026-08-24 | -$4.14M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-09-30 | -$27.40M 10-Q · filed 2025-11-05 | -$11.02M derived: sum of 2 quarters · filed 2026-08-24 | -$8.72M derived: sum of 3 quarters · filed 2026-08-24 | -$12.75M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2025-06-30 | $16.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $18.69M derived: sum of 2 quarters · filed 2026-08-24 | $14.65M derived: sum of 3 quarters · filed 2026-08-24 | $8.47M 10-K · filed 2026-08-24 | |||
| 2025-03-31 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | -$1.73M derived: sum of 2 quarters · filed 2026-05-06 | -$7.91M 10-Q · filed 2026-05-06 | -$18.51M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-12-31 | -$4.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | -$10.22M 10-Q · filed 2026-02-04 | -$20.82M derived: sum of 3 quarters · filed 2026-08-24 | -$10.93M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-09-30 | -$6.18M 10-Q · filed 2025-11-05 | -$16.78M derived: sum of 2 quarters · filed 2026-08-24 | -$6.89M derived: sum of 3 quarters · filed 2026-08-24 | $6.16M derived: sum of 4 quarters · filed 2026-08-24 | |||
| 2024-06-30 | -$10.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | -$714.00K derived: sum of 2 quarters · filed 2026-08-24 | $12.34M derived: sum of 3 quarters · filed 2026-08-24 | -$10.60M 10-K · filed 2026-08-24 | |||
| 2024-03-31 | $9.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-08 | $22.94M derived: sum of 2 quarters · filed 2025-05-08 | $0.00 10-Q · filed 2025-05-08 | -$6.34M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-12-31 | $13.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-06 | -$9.88M 10-Q · filed 2025-02-06 | -$16.23M derived: sum of 3 quarters · filed 2025-08-22 | -$25.81M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-09-30 | -$22.94M 10-Q · filed 2024-11-05 | -$29.28M derived: sum of 2 quarters · filed 2025-08-22 | -$38.86M derived: sum of 3 quarters · filed 2025-08-22 | -$28.37M derived: sum of 4 quarters · filed 2025-08-22 | |||
| 2023-06-30 | -$6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | -$15.93M derived: sum of 2 quarters · filed 2025-08-22 | -$5.43M derived: sum of 3 quarters · filed 2025-08-22 | -$2.49M 10-K · filed 2025-08-22 | |||
| 2023-03-31 | -$9.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-06 | $909.00K derived: sum of 2 quarters · filed 2024-05-06 | $3.85M 10-Q · filed 2024-05-06 | $15.72M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-12-31 | $10.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $13.44M 10-Q · filed 2024-02-07 | $25.31M derived: sum of 3 quarters · filed 2024-08-22 | $22.20M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-09-30 | $2.94M 10-Q · filed 2023-11-07 | $14.81M derived: sum of 2 quarters · filed 2024-08-22 | $11.71M derived: sum of 3 quarters · filed 2024-08-22 | $25.42M derived: sum of 4 quarters · filed 2024-08-22 | |||
| 2022-06-30 | $11.88M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $8.77M derived: sum of 2 quarters · filed 2024-08-22 | $22.48M derived: sum of 3 quarters · filed 2024-08-22 | $2.67M 10-K · filed 2024-08-22 | |||
| 2022-03-31 | -$3.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $10.61M derived: sum of 2 quarters · filed 2023-05-08 | -$9.21M 10-Q · filed 2023-05-08 | $690.00K derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-12-31 | $13.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-07 | -$6.10M 10-Q · filed 2023-02-07 | $3.80M derived: sum of 3 quarters · filed 2023-08-23 | $3.34M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-09-30 | -$19.82M 10-Q · filed 2022-11-07 | -$9.92M derived: sum of 2 quarters · filed 2023-08-23 | -$10.37M derived: sum of 3 quarters · filed 2023-08-23 | -$5.01M derived: sum of 4 quarters · filed 2023-08-23 | |||
| 2021-06-30 | $9.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $9.44M derived: sum of 2 quarters · filed 2023-08-23 | $14.81M derived: sum of 3 quarters · filed 2023-08-23 | $13.43M 10-K · filed 2023-08-23 | |||
| 2021-03-31 | -$454.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-09 | $4.91M derived: sum of 2 quarters · filed 2022-05-09 | $3.53M 10-Q · filed 2022-05-09 | -$13.86M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-12-31 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-07 | $3.98M 10-Q · filed 2022-02-07 | -$13.40M derived: sum of 3 quarters · filed 2022-08-24 | -$15.63M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-09-30 | -$1.38M 10-Q · filed 2021-11-08 | -$1.38M 10-Q · filed 2020-11-09 | -$21.00M derived: sum of 3 quarters · filed 2022-08-24 | -$9.85M derived: sum of 4 quarters · filed 2022-08-24 | |||
| 2020-06-30 | -$17.39M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | -$19.62M derived: sum of 2 quarters · filed 2022-08-24 | -$8.46M derived: sum of 3 quarters · filed 2022-08-24 | -$7.23M 10-K · filed 2022-08-24 | |||
| 2020-03-31 | -$2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-07 | $8.92M derived: sum of 2 quarters · filed 2021-05-07 | $10.15M 10-Q · filed 2021-05-07 | $9.10M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-12-31 | $11.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-02-08 | $12.39M 10-Q · filed 2021-02-08 | $11.34M derived: sum of 3 quarters · filed 2021-08-25 | $11.76M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-09-30 | $1.23M 10-Q · filed 2019-11-06 | $1.23M 10-Q · filed 2020-11-09 | $611.00K derived: sum of 3 quarters · filed 2021-08-25 | -$3.42M derived: sum of 4 quarters · filed 2021-08-25 | |||
| 2019-06-30 | -$1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | -$622.00K derived: sum of 2 quarters · filed 2021-08-25 | -$4.66M derived: sum of 3 quarters · filed 2021-08-25 | -$9.52M 10-K · filed 2021-08-25 | |||
| 2019-03-31 | $429.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | -$3.60M derived: sum of 2 quarters · filed 2020-05-11 | -$8.47M 10-Q · filed 2020-05-11 | $3.51M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-12-31 | -$4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | -$8.90M 10-Q · filed 2020-02-06 | $3.08M derived: sum of 3 quarters · filed 2020-08-26 | $8.68M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-09-30 | -$4.86M 10-Q · filed 2019-11-06 | $7.12M derived: sum of 2 quarters · filed 2020-08-26 | $12.71M derived: sum of 3 quarters · filed 2020-08-26 | $1.59M derived: sum of 4 quarters · filed 2020-08-26 | |||
| 2018-06-30 | $11.98M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $17.58M derived: sum of 2 quarters · filed 2020-08-26 | $6.45M derived: sum of 3 quarters · filed 2020-08-26 | $10.20M 10-K · filed 2020-08-26 | |||
| 2018-03-31 | $5.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-07 | -$5.53M derived: sum of 2 quarters · filed 2019-05-07 | -$1.78M 10-Q · filed 2019-05-07 | -$3.28M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-12-31 | -$11.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-07 | -$7.37M 10-Q · filed 2019-02-07 | -$8.87M derived: sum of 3 quarters · filed 2019-11-06 | -$6.54M derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-09-30 | $3.75M 10-Q · filed 2018-11-07 | $2.25M derived: sum of 2 quarters · filed 2019-11-06 | $3.75M 10-Q · filed 2017-11-09 | $502.00K derived: sum of 4 quarters · filed 2019-11-06 | |||
| 2017-06-30 | -$1.50M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $837.00K derived: sum of 2 quarters · filed 2019-11-06 | -$3.25M derived: sum of 3 quarters · filed 2019-11-06 | $699.00K 10-K/A · filed 2019-11-06 | |||
| 2017-03-31 | $2.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | -$1.75M derived: sum of 2 quarters · filed 2018-05-09 | $2.20M 10-Q · filed 2018-05-09 | $275.00K 10-Q · filed 2017-05-10 | $1.94M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-12-31 | -$4.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-08 | -$138.00K 10-Q · filed 2018-02-08 | -$1.73M 10-Q · filed 2017-02-09 | -$402.00K derived: sum of 3 quarters · filed 2018-08-27 | $1.39M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-09-30 | $3.95M 10-Q · filed 2017-11-09 | $2.85M 10-Q · filed 2016-11-09 | $3.68M derived: sum of 2 quarters · filed 2018-08-27 | $3.95M 10-Q · filed 2017-11-09 | -$1.96M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-06-30 | -$264.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $1.53M derived: sum of 2 quarters · filed 2018-08-27 | -$5.91M derived: sum of 3 quarters · filed 2018-08-27 | $298.00K 10-K · filed 2018-08-27 | |||
| 2016-03-31 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | -$5.64M derived: sum of 2 quarters · filed 2017-05-10 | $562.00K 10-Q · filed 2017-05-10 | -$405.00K derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-12-31 | -$7.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$1.23M 10-Q · filed 2017-02-09 | -$2.20M derived: sum of 3 quarters · filed 2017-09-07 | $1.40M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-09-30 | $6.20M 10-Q · filed 2016-11-09 | $5.24M derived: sum of 2 quarters · filed 2017-09-07 | $8.83M derived: sum of 3 quarters · filed 2017-09-07 | $6.96M derived: sum of 4 quarters · filed 2017-09-07 | |||
| 2015-06-30 | -$967.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $2.63M derived: sum of 2 quarters · filed 2017-09-07 | $754.00K derived: sum of 3 quarters · filed 2017-09-07 | $1.88M 10-K · filed 2017-09-07 | |||
| 2015-03-31 | $3.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $1.72M derived: sum of 2 quarters · filed 2016-05-10 | $2.85M 10-Q · filed 2016-05-10 | -$2.24M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-12-31 | -$1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$749.00K 10-Q · filed 2016-02-09 | -$5.83M derived: sum of 3 quarters · filed 2016-08-29 | -$2.04M derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-09-30 | $1.13M 10-Q · filed 2015-11-09 | -$3.96M derived: sum of 2 quarters · filed 2016-08-29 | -$162.00K derived: sum of 3 quarters · filed 2016-08-29 | -$903.00K derived: sum of 4 quarters · filed 2016-08-29 | |||
| 2014-06-30 | -$5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | -$1.29M derived: sum of 2 quarters · filed 2016-08-29 | -$2.03M derived: sum of 3 quarters · filed 2016-08-29 | -$1.94M 10-K · filed 2016-08-29 | |||
| 2014-03-31 | $3.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $3.06M derived: sum of 2 quarters · filed 2015-05-11 | $3.15M 10-Q · filed 2015-05-11 | $1.19M derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-12-31 | -$741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-09 | -$650.00K 10-Q · filed 2015-02-09 | -$2.60M derived: sum of 3 quarters · filed 2015-08-31 | -$471.00K derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-09-30 | $91.00K 10-Q · filed 2014-11-10 | -$1.86M derived: sum of 2 quarters · filed 2015-08-31 | $270.00K derived: sum of 3 quarters · filed 2015-08-31 | $36.00K derived: sum of 4 quarters · filed 2015-08-31 | |||
| 2013-06-30 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $179.00K derived: sum of 2 quarters · filed 2015-08-31 | -$55.00K derived: sum of 3 quarters · filed 2015-08-31 | -$837.00K 10-K · filed 2015-08-31 | |||
| 2013-03-31 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-12 | $1.90M derived: sum of 2 quarters · filed 2014-05-12 | $1.12M 10-Q · filed 2014-05-12 | $3.81M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-12-31 | -$234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-04 | -$1.02M 10-Q · filed 2014-02-04 | $1.68M derived: sum of 3 quarters · filed 2014-08-29 | $1.33M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-09-30 | -$782.00K 10-Q · filed 2013-11-12 | $1.91M derived: sum of 2 quarters · filed 2014-08-29 | $1.56M derived: sum of 3 quarters · filed 2014-08-29 | -$1.39M derived: sum of 4 quarters · filed 2014-08-29 | |||
| 2012-06-30 | $2.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $2.35M derived: sum of 2 quarters · filed 2014-08-29 | -$608.00K derived: sum of 3 quarters · filed 2014-08-29 | -$2.06M 10-K · filed 2014-08-29 | |||
| 2012-03-31 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-10 | -$3.30M derived: sum of 2 quarters · filed 2013-05-10 | -$4.75M 10-Q · filed 2013-05-10 | -$3.25M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-12-31 | -$2.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-02-11 | -$4.40M 10-Q · filed 2013-02-11 | -$2.90M derived: sum of 3 quarters · filed 2013-08-29 | -$1.93M derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-09-30 | -$1.45M 10-Q · filed 2012-11-09 | $54.00K derived: sum of 2 quarters · filed 2013-08-29 | $1.03M derived: sum of 3 quarters · filed 2013-08-29 | $377.00K derived: sum of 4 quarters · filed 2013-08-29 | |||
| 2011-06-30 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $2.48M derived: sum of 2 quarters · filed 2013-08-29 | $1.83M derived: sum of 3 quarters · filed 2013-08-29 | $3.43M 10-K · filed 2013-08-29 | |||
| 2011-03-31 | $974.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-10 | $323.00K derived: sum of 2 quarters · filed 2012-05-10 | $1.93M 10-Q · filed 2012-05-10 | ||||
| 2010-12-31 | -$651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-07 | $956.00K 10-Q · filed 2012-02-07 | |||||
| 2010-09-30 | $1.61M 10-Q · filed 2011-11-09 | ||||||
| 2010-06-30 | -$1.52M 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |